Apontis Pharma aus Monheim am Rhein hat sich insbesondere auf die Indikationen Herz-Kreislauf-Erkrankungen, Atemwegserkrankungen sowie Diabetes spezialisiert. Die Wurzeln gehen zurück auf die frühere Schwarz Pharma. Der Börsengang erfolgte im Mai 2021.
INVESTOR TERMSHEET
APPH/D

Apontis Pharma
#BGFL Mood: Negative · #BGFL-Indicator: Reduce · Review date: 16.10.2024
LEI: 894500ETO1J6MR8PDF91
SECTOR: Gesundheit SUB-SECTOR: Pharma
NAME
Apontis Pharma
WKN
A3CMGM
ISIN
DE000A3CMGM5
TICKER
APPH
INDEX
EXCHANGE
Xetra
Made with ❤ von BGFL

DIVIDENDS PER SHARE (Visualized)

Dividends enjoy enormous popularity, especially among private investors. They are paid out shortly after the Annual General Meeting, but the shares are also traded ‘exD’, i.e. with a dividend deduction, shortly beforehand. On average, most companies pay out around 30 per cent of their profits to shareholders.

DIVIDENDS PER SHARE (in numbers)

2017 2018 2019 2020 2021 2022 2023e 2024e 2025e 2026e
0,00 0,00 0,00 0,00 0,00 0,00 0,00 - 0,00 0,00
- +0,00 +0,00 +0,00 +0,00 +0,00 +0,00 +0,00 +0,00 +0,00
- +0,00% +0,00% +0,00% +0,00% +0,00% +0,00% +0,00% +0,00% +0,00%

A reliable dividend policy is very popular with investors. Here we show the development of the dividend payout over a longer period of time and also indicate the absolute and percentage changes compared to the previous year.

Lorem sit non do eiusmod officia duis excepteur sit. Do officia mollit proident officia quis dolore laboris velit voluptate laboris. Esse irure mollit reprehenderit incididunt occaecat in Lorem aliqua consectetur laboris ex laboris. Consequat velit dolore sit aliquip eiusmod labore commodo eu nisi aliqua mollit dolore irure. Non in irure mollit ut consequat fugiat et exercitation exercitation voluptate nulla.

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL